Related Experiment Video
Updated: Aug 9, 2026
07:23
Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Pain control: opioid dosing, population kinetics and side-effects
Sinno H P Simons1, K J S Anand
1Department of Pediatric Surgery, Erasmus-MC/Sophia Children's Hospital, Rotterdam, The Netherlands. sinnosimons@hotmail.com
Seminars in Fetal & Neonatal Medicine
|April 20, 2006
Summary
Opioid use in neonates should be limited to severe pain, prioritizing continuous infusions. Further research is needed on long-term effects and individualized dosing for infant pain management.
Area of Science:
- Neonatal intensive care
- Pharmacology
- Pain management
Background:
- Neonates often require opioids for pain and stress during invasive procedures, surgery, or ventilation.
- Morphine and fentanyl are commonly used, with randomized trials evaluating their efficacy and safety.
Purpose of the Study:
- To summarize current evidence on opioid dosing in newborns.
- To review opioid side effects and their impact on neonates.
- To explore advanced modeling techniques for analyzing clinical trial data.
Main Methods:
- Review of randomized clinical trials on opioid use in neonates.
- Analysis of population kinetics and non-linear mixed-effects modeling.
- Synthesis of current evidence on opioid safety and efficacy.
Main Results:
- Opioid use should be reserved for severe pain, preferably via continuous infusion.
- Limited data exists on the long-term outcomes of prolonged opioid exposure in neonates.
- Pharmacodynamics and pharmacogenetics of neonatal opioid use require further investigation.
Conclusions:
- Current opioid use in neonates necessitates careful consideration for severe pain management.
- Individualized therapy, driven by advanced modeling, is crucial for optimizing neonatal pain relief.
- Further research into long-term effects and individualized dosing is essential for safe and effective neonatal pain management.
Related Concept Videos
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...